CAM
EW icon

Costello Asset Management’s Edwards Lifesciences EW Stock Holding History

Costello Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.3K Buy
600
+200
+50% +$16.8K 0.02% 237
2026
Q1 		$32K Hold
400
– – 0.01% 308
2025
Q4 		$34.1K Hold
400
– – 0.01% 289
2025
Q3 		$31.1K Hold
400
– – 0.01% 312
2025
Q2 		$31.3K Hold
400
– – 0.01% 302
2025
Q1 		$29K Buy
+400
New +$28.6K 0.01% 301

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Costello Asset Management's EW Position: Q2 2026 in Review

Costello Asset Management increased its Edwards Lifesciences (EW) stake by 50% in Q2 2026, buying an estimated $16.8K and bringing the position to 600 shares worth $54.3K. The position accounts for 0.02% of the portfolio, ranked #237.

Costello Asset Management first reported a position in EW in Q1 2025 and has held it in 6 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Costello Asset Management held 600 shares of Edwards Lifesciences worth $54.3K as of Q2 2026.
  • Costello Asset Management bought 200 Edwards Lifesciences shares in Q2 2026, an estimated $16.8K.
  • Edwards Lifesciences made up 0.02% of Costello Asset Management's portfolio in Q2 2026, its #237 holding.
  • Costello Asset Management first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.